The Brazilian pharmaceutical company Chemical Union announced on Friday (23.out.2020) that it closed an agreement to produce the Sputnik V, Russian vaccine against covid-19. According to the company, production should start in the second half of November. The laboratory still needs approval from Anvisa (National Health Surveillance Agency).
The drugmaker said it has signed a confidentiality agreement with the RDIF (Russian Direct Investment Fund). Therefore, it cannot give technical details of the partnership.
“We have the contract to be the producer for Brazil and for all of Latin America ”, said Fernando Castro Marques, president of União Química to National Newspaper, gives TV Globo. “It is evident that, for this to happen, it will depend on Anvisa to authorize and validate the entire process and grant registration of the vaccine. ”
In an interview with CNN Brasil, the pharmacist stated that it has already received part of the inputs for the production of the immunizer. According to the director of international business at União Química, Rogério Rosso, the material is part of 1 pilot lot, which will be used for research and development.
“After that, we will have the vector templates, clinical studies and we will ask for the necessary records ”, explained Natasha Kuniechick, biotechnology coordinator Grupo União Química.
Sputnik V is being developed by the Gamaleya Research Institute in Moscow. Approved in Russia on August 11, it became the 1st vaccine to be endorsed to be mass produced and applied. At the time, the attitude of the Vladimir Putin government was criticized by scientists for the lack of published studies on the tests.
On September 4, the scientific journal The Lancet released study (whole – 661 KB) which points out that vaccine from Russia had no adverse effects and induced an immune response to the new coronavirus. The study shows results for phases 1 and 2 of Sputnik V testing. Phase 3 of the vaccine is still ongoing.
Russia closed an agreement with the government of Paraná to test and produce the vaccine in Brazil. The government of Bahia has also signed a partnership to carry out phase 3 of tests for the immunizer.
Brazil conducts tests for another 4 vaccines against covid-19:
- Oxford University / AstraZeneca;
- Sinovac Biotech;
- Johnson & Johnson.